A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if it is safe and effective to give delavirdine (DLV) in combination with two or three other drugs to HIV-infected patients. The drugs to be used in combination with DLV are zidovudine (ZDV), indinavir (IDV), and lamivudine (3TC).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pharmacia and Upjohn
• Treatments: Delavirdine; Indinavir; Lamivudine; Zidovudine

Criteria

Inclusion Criteria

Prior Medication:

Allowed:

Less than 1 month prior treatment with zidovudine.

Exclusion Criteria

Prior Medication:

Excluded:

• Prior indinavir.

• Prior lamivudine.

• Prior protease inhibitors.

• Prior non-nucleoside reverse transcriptase inhibitors.

• 1 month or more prior zidovudine.

1. HIV-1 positive.

• CD4 coun tis above 50.

• HIV-1 RNA levels greater than 20,000.